Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline ...

Dr Ignatius Luke Chan, PhD, ACLP, investigates the current technological revolution and changes in the research paradigm of ...

Workforce readiness and retention strategies are critical to sustain business stability during and after the transition.

CoreWeave, a hyperscaler startup backed by Nvidia, is targeting a valuation of up to $26 billion with its IPO.

Fintech firm Klarna Group has filed its prospectus for a U.S. initial public offering, moving ahead with plans to list even ...

The buy now, pay later provider detailed its profit trajectory and growth plans in a prospectus filed earlier this month.

2.4% of IceCure Medical shares are held by insiders. Comparatively, 11.1% of Paradigm Medical Industries shares are held by insiders. Strong institutional ownership is an indication that large ...

The European IPO market’s future looks promising, bolstered by 2024’s performance, strong listing pipeline and improving ...

HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.